What is Bortezomib: Uses, Dosage, Side Effects and More

Bortezomib is a targeted cancer medication that helps treat certain blood cancers by blocking specific proteins that cancer cells need to survive. This prescription medicine works differently from traditional chemotherapy drugs, offering hope for people with multiple myeloma and some types of lymphoma.

Your doctor might recommend bortezomib as part of your cancer treatment plan, and understanding how it works can help you feel more prepared for your journey ahead.

What is Bortezomib?

Bortezomib is a type of cancer medicine called a proteasome inhibitor. Think of proteasomes as tiny recycling centers inside cells that break down old or damaged proteins.

Cancer cells rely heavily on these recycling centers to stay alive and multiply. Bortezomib blocks these proteasomes, which causes cancer cells to build up toxic proteins and eventually die. Normal cells can handle this disruption better than cancer cells, which is why this targeted approach can be effective.

This medication belongs to a class of drugs specifically designed to target the unique ways cancer cells function, making it a valuable tool in modern cancer treatment.

What is Bortezomib Used For?

Bortezomib is primarily used to treat multiple myeloma, a type of blood cancer that affects plasma cells in your bone marrow. It's also approved for treating mantle cell lymphoma, another form of blood cancer.

Your doctor might prescribe bortezomib if you've been newly diagnosed with multiple myeloma or if your cancer has returned after previous treatments. The medication can be used alone or combined with other cancer drugs, depending on your specific situation.

Sometimes doctors use bortezomib for other types of blood cancers when standard treatments haven't worked well. Your healthcare team will discuss whether this medication is right for your particular type and stage of cancer.

How Does Bortezomib Work?

Bortezomib is considered a moderately strong cancer medication that works by targeting a specific weakness in cancer cells. It blocks proteasomes, which are like cellular garbage disposals that break down proteins.

When these proteasomes stop working properly, cancer cells can't get rid of damaged proteins. This buildup of toxic proteins triggers the cancer cells to die naturally, a process called apoptosis. Your healthy cells are generally better at surviving this disruption than cancer cells.

The medication doesn't work instantly like some drugs. Instead, it gradually builds up in your system over several treatment cycles, which is why your doctor will monitor your response carefully throughout treatment.

How Should I Take Bortezomib?

Bortezomib is given as an injection, either into a vein (intravenous) or under the skin (subcutaneous). You cannot take this medication by mouth at home.

Your healthcare team will administer the injection in a clinic or hospital setting. The subcutaneous injection, which goes under your skin, is often preferred because it may cause fewer side effects than the intravenous method. The injection typically takes just a few minutes to complete.

You don't need to eat or drink anything special before your injection. However, staying well-hydrated by drinking plenty of water throughout your treatment days can help your body process the medication more effectively.

Your doctor will likely recommend taking anti-nausea medication before your treatment if you're prone to stomach upset. Some people find eating a light snack beforehand helps prevent nausea.

How Long Should I Take Bortezomib For?

The length of bortezomib treatment varies greatly depending on your specific cancer type, how well you respond to the medication, and what other treatments you're receiving. Most people receive treatment in cycles that last several weeks.

A typical treatment cycle might involve receiving bortezomib twice a week for two weeks, followed by a rest period. You might go through four to eight cycles, but some people need more or fewer cycles based on how their cancer responds.

Your doctor will regularly check your blood work and scan results to see how well the treatment is working. If your cancer is responding well and you're tolerating the medication, treatment might continue for several months.

Never stop taking bortezomib without talking to your doctor first, even if you're feeling better. Your healthcare team needs to carefully plan when and how to end treatment to give you the best chance of long-term success.

What Are the Side Effects of Bortezomib?

Like most cancer medications, bortezomib can cause side effects, though not everyone experiences them. Understanding what to expect can help you prepare and know when to contact your healthcare team.

Here are the more common side effects you might experience:

• Fatigue and weakness that may worsen over time
• Nausea and vomiting, especially in the first few days after treatment
• Diarrhea or constipation
• Loss of appetite
• Nerve pain or tingling in hands and feet (peripheral neuropathy)
• Low blood cell counts, which can increase infection risk
• Fever and chills
• Headaches
• Dizziness or lightheadedness

These common side effects are usually manageable with supportive care and medications your doctor can prescribe.

Some people may experience more serious but less common side effects that require immediate medical attention:

• Severe nerve damage causing significant pain or numbness
• Heart problems, including heart failure or irregular heartbeat
• Severe drops in blood pressure
• Lung problems or difficulty breathing
• Severe infections due to weakened immune system
• Liver problems
• Tumor lysis syndrome, where cancer cells break down too quickly
• Severe skin reactions

While these serious side effects are less common, your healthcare team will monitor you closely throughout treatment to catch any problems early.

Who Should Not Take Bortezomib?

Bortezomib isn't suitable for everyone, and your doctor will carefully review your medical history before prescribing it. People with certain health conditions may need to avoid this medication or require special monitoring.

Your doctor will likely recommend against bortezomib if you have:

• Severe heart disease or recent heart attack
• Severe liver disease
• Active, uncontrolled infections
• Severe nerve problems or neuropathy
• Known allergy to bortezomib or its ingredients
• Severe kidney disease

Pregnancy and breastfeeding require special consideration, as bortezomib can harm developing babies.

Your doctor will also be cautious about prescribing bortezomib if you have diabetes, lung disease, or a history of shingles. These conditions don't necessarily prevent you from taking the medication, but they may require closer monitoring or dose adjustments.

Bortezomib Brand Names

Bortezomib is available under the brand name Velcade, which is the most commonly prescribed version. This brand name formulation has been extensively studied and proven effective in clinical trials.

Generic versions of bortezomib are also available, which contain the same active ingredient as Velcade but may be less expensive. Your insurance plan and healthcare provider will help determine which version is best for you.

Whether you receive brand name or generic bortezomib, the medication works the same way and has the same effectiveness. Your pharmacist can answer any questions about the specific formulation you'll be receiving.

Bortezomib Alternatives

If bortezomib isn't right for you or stops working effectively, several alternative treatments are available for multiple myeloma and lymphoma. Your doctor will choose alternatives based on your specific situation and treatment history.

Other proteasome inhibitors like carfilzomib (Kyprolis) and ixazomib (Ninlaro) work similarly to bortezomib but may have different side effect profiles. Carfilzomib is given intravenously, while ixazomib comes as a pill you can take at home.

Immunomodulatory drugs such as lenalidomide (Revlimid) and pomalidomide (Pomalyst) work differently by helping your immune system fight cancer cells. These medications are taken as pills and are often combined with other treatments.

Newer treatments like monoclonal antibodies (daratumumab, elotuzumab) and CAR-T cell therapy represent cutting-edge approaches that may be options depending on your specific situation.

Is Bortezomib Better Than Lenalidomide?

Both bortezomib and lenalidomide are effective treatments for multiple myeloma, but they work in different ways and may be better suited for different situations. There's no single "better" medication, as the choice depends on your individual circumstances.

Bortezomib often works faster than lenalidomide, making it a good choice when you need rapid disease control. It's also effective for people with certain high-risk genetic features of multiple myeloma. However, the nerve-related side effects can be challenging for some people.

Lenalidomide is taken as a pill at home, which many people find more convenient than coming to the clinic for injections. It tends to cause less nerve damage but can increase the risk of blood clots and may cause more fatigue.

Many doctors use both medications together or in sequence, as they complement each other well. Your healthcare team will consider factors like your age, overall health, kidney function, and personal preferences when deciding which approach is best for you.